Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Marcus

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Clinical and Laboratory Haematology|March 1, 1996
Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotoninP Mahendra, D M Keeling, I M Hood, et al.
Lancet (London, England)|March 24, 1984
Maintenance and consolidation therapy in AMLR E Marcus, D Catovsky, J M Goldman, et al.
Bone Marrow Transplantation|June 5, 1998
Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CMLS L Rahman, P Mahendra, E Nacheva, et al.
The American Journal of Otology|July 1, 1984
Pneumolabyrinth: a new radiologic sign for fracture of the stapes footplateM F Mafee, G E Valvassori, A Kumar, et al.
British Journal of Haematology|November 1, 1993
BCR rearrangement in apparent essential thrombocythaemiaE M Richards, D M Bloxham, E Nacheva, et al.
Bone Marrow Transplantation|December 1, 1994
Liquid storage of peripheral blood progenitor cells for transplantationH K Jestice, M A Scott, S Ager, et al.
Clinical and Laboratory Haematology|January 1, 1992
Intra-ocular haemorrhage, a frequent complication of acute promyelocytic leukaemiaE M Richards, R E Marcus, P Harper, et al.
British Journal of Haematology|November 1, 1984
Red cell removal from donor bone marrowH M Jones, D C Linch, R E Marcus, et al.
Bone Marrow Transplantation|February 26, 1999
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipientsM K Gandhi, K Jestice, M A Scott, et al.
Bone Marrow Transplantation|March 1, 1996
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity studyS Ager, P Mahendra, E M Richards, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Clinical and Laboratory Haematology|March 1, 1996
Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotoninP Mahendra, D M Keeling, I M Hood, et al.
Lancet (London, England)|March 24, 1984
Maintenance and consolidation therapy in AMLR E Marcus, D Catovsky, J M Goldman, et al.
Bone Marrow Transplantation|June 5, 1998
Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CMLS L Rahman, P Mahendra, E Nacheva, et al.
The American Journal of Otology|July 1, 1984
Pneumolabyrinth: a new radiologic sign for fracture of the stapes footplateM F Mafee, G E Valvassori, A Kumar, et al.
British Journal of Haematology|November 1, 1993
BCR rearrangement in apparent essential thrombocythaemiaE M Richards, D M Bloxham, E Nacheva, et al.
Bone Marrow Transplantation|December 1, 1994
Liquid storage of peripheral blood progenitor cells for transplantationH K Jestice, M A Scott, S Ager, et al.
Clinical and Laboratory Haematology|January 1, 1992
Intra-ocular haemorrhage, a frequent complication of acute promyelocytic leukaemiaE M Richards, R E Marcus, P Harper, et al.
British Journal of Haematology|November 1, 1984
Red cell removal from donor bone marrowH M Jones, D C Linch, R E Marcus, et al.
Bone Marrow Transplantation|February 26, 1999
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipientsM K Gandhi, K Jestice, M A Scott, et al.
Bone Marrow Transplantation|March 1, 1996
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity studyS Ager, P Mahendra, E M Richards, et al.
Pageof 13